BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24055840)

  • 21. Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics.
    Thomas A; Lenglet S; Chaurand P; Deglon J; Mangin P; Mach F; Steffens S; Wolfender JL; Staub C
    Thromb Haemost; 2011 Jul; 106(1):20-33. PubMed ID: 21614412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of lipid-based formulations in drug discovery.
    Chen XQ; Gudmundsson OS; Hageman MJ
    J Med Chem; 2012 Sep; 55(18):7945-56. PubMed ID: 22779739
    [No Abstract]   [Full Text] [Related]  

  • 23. Noninvasive structural, functional, and molecular imaging in drug development.
    Rudin M
    Curr Opin Chem Biol; 2009 Jun; 13(3):360-71. PubMed ID: 19447067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipidomics in nutrition and food research.
    Hyötyläinen T; Bondia-Pons I; Orešič M
    Mol Nutr Food Res; 2013 Aug; 57(8):1306-18. PubMed ID: 23413227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems biology approaches to study lipidomes in health and disease.
    Alves MA; Lamichhane S; Dickens A; McGlinchey A; Ribeiro HC; Sen P; Wei F; Hyötyläinen T; Orešič M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Feb; 1866(2):158857. PubMed ID: 33278596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipidomics analysis in drug discovery and development.
    Kostidis S; Sánchez-López E; Giera M
    Curr Opin Chem Biol; 2023 Feb; 72():102256. PubMed ID: 36586190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane lipidomics for the discovery of new antiparasitic drug targets.
    Maréchal E; Riou M; Kerboeuf D; Beugnet F; Chaminade P; Loiseau PM
    Trends Parasitol; 2011 Nov; 27(11):496-504. PubMed ID: 21862412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipidomics era: accomplishments and challenges.
    Bou Khalil M; Hou W; Zhou H; Elisma F; Swayne LA; Blanchard AP; Yao Z; Bennett SA; Figeys D
    Mass Spectrom Rev; 2010; 29(6):877-929. PubMed ID: 20931646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipidomics in drug development.
    Dehairs J; Derua R; Rueda-Rincon N; Swinnen JV
    Drug Discov Today Technol; 2015 Jun; 13():33-8. PubMed ID: 26190681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the future of mass-spectrometry-based lipidomics.
    Loizides-Mangold U
    FEBS J; 2013 Jun; 280(12):2817-29. PubMed ID: 23432956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A map of Alzheimer's disease-signaling pathways: a hope for drug target discovery.
    Ogishima S; Mizuno S; Kikuchi M; Miyashita A; Kuwano R; Tanaka H; Nakaya J
    Clin Pharmacol Ther; 2013 May; 93(5):399-401. PubMed ID: 23511713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits.
    Benetti F; Gustincich S; Legname G
    Expert Opin Drug Discov; 2012 Mar; 7(3):245-59. PubMed ID: 22468955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uncovering the therapeutic potential of natural products with biomarker-guided screening.
    Kawamura A
    IDrugs; 2010 May; 13(5):321-4. PubMed ID: 20432189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mediator lipidomics.
    Serhan CN
    Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):4-14. PubMed ID: 16099386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How to study lipidomes.
    Seppänen-Laakso T; Oresic M
    J Mol Endocrinol; 2009 Mar; 42(3):185-90. PubMed ID: 19060177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical genetics-based target identification in drug discovery.
    Cong F; Cheung AK; Huang SM
    Annu Rev Pharmacol Toxicol; 2012; 52():57-78. PubMed ID: 21819237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesopore-assisted profiling strategies in clinical proteomics for drug/target discovery.
    Savino R; Terracciano R
    Drug Discov Today; 2012 Feb; 17(3-4):143-52. PubMed ID: 22016086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipidomics of Alzheimer's disease.
    Touboul D; Gaudin M
    Bioanalysis; 2014 Feb; 6(4):541-61. PubMed ID: 24568356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipidomics: a new window to biomedical frontiers.
    Oresic M; Hänninen VA; Vidal-Puig A
    Trends Biotechnol; 2008 Dec; 26(12):647-52. PubMed ID: 18951641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel aspects of systems biology and clinical cytomics.
    Bocsi J; Mittag A; Sack U; Gerstner AO; Barten MJ; Tárnok A
    Cytometry A; 2006 Mar; 69(3):105-8. PubMed ID: 16479593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.